Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  trimetrexate glucuronate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 70 for your search:
Start Over
Phase II/III Randomized Comparison of Two Schedules of TMTX vs 5-FU in Patients with Colorectal Carcinoma (Summary Last Modified 11/88)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8611
Phase I/II Chemotherapy with Trimetrexate in Children with Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8591
Phase I/II Pilot Study of Chemotherapy with CDDP/TMTX or TMTX/VP-16 in Patients with non-Small Cell Lung Cancer (Summary Last Modified 09/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: YALE-HIC-4467, NCI-V88-0377
Phase II Study of TMTX/5-FU/CF in Recurrent or Refractory Metastatic Urothelial Tract Cancer (Summary Last Modified 07/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: MSKCC-93150, NCI-V94-0477
Phase II Study of TMTX/5-FU/CF for Previously Untreated, Unresectable or Metastatic Gastric Cancer (Summary Last Modified 05/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: USB-TMTX-B018, UPCC-1294, NCI-V94-0528
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: 95-093, P30CA008748, MSKCC-95093, NCI-V96-0840, NCT00002738
Phase II Study of Trimetrexate for Advanced, Persistent, or Recurrent Mixed Mesodermal Tumors of the Uterus
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-130C
Phase II Study of Trimetrexate in Refractory Leiomyosarcoma of the Uterus
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-131D
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065428 (3P-95-1), LAC-USC-3P951, NCI-G97-1173, NCT00002955
Phase II Study of Trimetrexate Glucuronate and Continuous Infusion Fluorouracil in Previously Untreated Patients with Locally Advanced or Metastatic Pancreatic Cancer (Summary Last Modified 11/1999)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UCLA-HSPC-971201401, USB-UCLA-HSPC-971201401, NCI-V98-1409
Phase II Chemotherapy with Trimetrexate in Patients with Advanced Sarcomas (Summary Last Modified 11/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: DFCI-87083, NCI-T88-0015D, T88-0015
Phase II Study of TMTX in Patients with Metastatic Breast or Head and Neck Tumors Refractory to Conventional Therapy or for Whom No Conventional Therapy Exists
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor:
Protocol IDs: WL/PD-898, AECM-8509201, BGSM-99885, NCI-V85-0228
Phase II Chemotherapy with TMTX in Patients with Endocrine Therapy-Resistant Metastatic Adenocarcinoma of the Prostate (Summary Last Modified 12/87)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: UMCC-8525, MSKCC-86100, NCI-T85-0265C, T85-0265
Phase II Chemotherapy with TMTX in Patients with Advanced Ovarian Cancer Who Have Failed Prior Chemotherapy (Summary Last Modified 03/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: UMCC-8603, NCI-T86-0047C, T86-0047
Phase II Chemotherapy with Trimetrexate in Patients with Advanced Uterine Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCC-8604, NCI-T86-0048C, T86-0048
Phase II Master Protocol for Controlled Studies in the Treatment of Advanced Renal Cell Cancer --- Trimetrexate
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-2885
Phase II Chemotherapy with Trimetrexate in Patients with Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND28, NCI-T86-0130W, T86-0130, IND28
Phase II Chemotherapy with Trimetrexate in Patients with Advanced Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-85070801, NCI-T86-0071D, T86-0071
Phase II Chemotherapy with TMTX in Patients with Advanced Unresectable Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8650, NCI-T85-0223C, T85-0223
Phase II Chemotherapy with Trimetrexate in Patients with Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND26, NCI-T86-0128W, T86-0128, IND26
Phase II Chemotherapy with Trimetrexate in Patients with Malignant Glioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND27, NCI-T86-0129W, T86-0129, IND27
Start Over